Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
- PMID: 31247901
- PMCID: PMC6651067
- DOI: 10.3390/molecules24132350
Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) is one of the most frequent cancers, and to date, there have been very few drugs available that can improve survival, the most well-known being sorafenib. The pathogenesis of HCC is complex, involving multiple processes including abnormal cell and tissue regeneration, angiogenesis, genomic instability, cellular proliferation, and signaling pathway alterations. Capsaicin is a substance that holds increasingly high interest and is studied as a therapeutic option in a wide array of diseases. Several studies have investigated capsaicin roles in various stages of HCC oncogenesis. This paper aims to thoroughly detail the available information on the individual effects of capsaicin on the cellular mechanisms and pathways involved in HCC development, as well as investigate their possible cooperation and interferences. The synergistic antitumor effects of capsaicin and sorafenib are also addressed.
Keywords: apoptosis; autophagy; capsaicin; hepatocellular carcinoma; oxidative stress; pathogenesis; regeneration; signaling pathways; tumorigenesis.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling.Oncol Rep. 2018 Dec;40(6):3235-3248. doi: 10.3892/or.2018.6754. Epub 2018 Oct 1. Oncol Rep. 2018. PMID: 30272354 Free PMC article.
-
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).J Hepatol. 2010 Jan;52(1):79-87. doi: 10.1016/j.jhep.2009.10.008. Epub 2009 Oct 28. J Hepatol. 2010. PMID: 19910069
-
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy.J Pharm Pharmacol. 2021 Sep 7;73(10):1369-1376. doi: 10.1093/jpp/rgab070. J Pharm Pharmacol. 2021. PMID: 34014301
-
Anticancer Properties of Capsaicin Against Human Cancer.Anticancer Res. 2016 Mar;36(3):837-43. Anticancer Res. 2016. PMID: 26976969 Review.
-
The potential antitumor effects of capsaicin.Prog Drug Res. 2014;68:181-208. doi: 10.1007/978-3-0348-0828-6_8. Prog Drug Res. 2014. PMID: 24941670 Review.
Cited by
-
Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer.Front Oncol. 2022 Jul 13;12:908487. doi: 10.3389/fonc.2022.908487. eCollection 2022. Front Oncol. 2022. PMID: 35912207 Free PMC article.
-
Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias.Curr Issues Mol Biol. 2024 Sep 2;46(9):9721-9759. doi: 10.3390/cimb46090578. Curr Issues Mol Biol. 2024. PMID: 39329930 Free PMC article. Review.
-
Multiple Myeloma Inhibitory Activity of Plant Natural Products.Cancers (Basel). 2021 May 29;13(11):2678. doi: 10.3390/cancers13112678. Cancers (Basel). 2021. PMID: 34072312 Free PMC article. Review.
-
Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications.Front Mol Neurosci. 2023 Aug 17;16:1239599. doi: 10.3389/fnmol.2023.1239599. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37664239 Free PMC article. Review.
-
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.Anal Cell Pathol (Amst). 2019 Nov 26;2019:9423907. doi: 10.1155/2019/9423907. eCollection 2019. Anal Cell Pathol (Amst). 2019. PMID: 31886121 Free PMC article. Review.
References
-
- Adami H.-O., Hunter D.J., Trichopoulos D. Textbook of Cancer Epidemiology. Oxford University Press; New York, NY, USA: 2008.
Publication types
MeSH terms
Substances
Grants and funding
- 7PFE/16.10.2018/Ministry of Research and Innovation in Romania
- PN.19.29.01.01/2019/Ministry of Research and Innovation in Romania
- PN-III-P1-1.2-PCCDI-2017-0341/Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
- PN-III-P1-1.2-PCCDI-2017-0782/Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
LinkOut - more resources
Full Text Sources